Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion type Assertion NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_head.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion description "[Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) within 3 h after onset of focal cerebral ischemia was approved in Germany in August 2000.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_provenance.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion evidence source_evidence_literature NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_provenance.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion SIO_000772 16912477 NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_provenance.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion wasDerivedFrom befree-20140225 NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_provenance.
- NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_assertion wasGeneratedBy ECO_0000203 NP258626.RAqdGfgeAovW0vC3nKbPuX1K4HPqlUdGotVSCt-LDiIJU130_provenance.